UMIN ID: UMIN000054351
Registered date:01/06/2024
Prospective randomized controlled trial between lemborexant and benzodiazepine for pancreatobiliary patients with high risk factor of delirium
Basic Information
Recruitment status | Pending |
---|---|
Health condition(s) or Problem(s) studied | Pancreatobiliary patents with high risk factor of delirium |
Date of first enrollment | 2024/06/01 |
Target sample size | 90 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | benzodiazepine lemborexant |
Outcome(s)
Primary Outcome | The incidence rate of delirium |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | 99years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1 Undertaken antipsychotic drugs 2 Undertaken sleeping pills 3 Refusal to participate this study |
Related Information
Primary Sponsor | Osaka Medical and Pharmaceutical University |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Osaka Medical and Pharmaceutical University |
Secondary ID(s) |
Contact
public contact | |
Name | Takeshi Ogura |
Address | 2-7 Daigakuchou, Takatsukishi, Osaka Japan 569-8686 |
Telephone | 072-683-1221 |
oguratakeshi0411@yahoo.co.jp | |
Affiliation | Osaka Medical and Pharmaceutical University Hospital Endoscopy Center |
scientific contact | |
Name | Takeshi Ogura |
Address | 2-7 Daigakuchou, Takatsukishi, Osaka Japan |
Telephone | 072-683-1221 |
oguratakeshi0411@yahoo.co.jp | |
Affiliation | Osaka Medical and Pharmaceutical University Hospital Endoscopy Center |